Our ******* ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Management is intentionally prioritizing commercial channel quality and long-term value creation over 'growth at all costs,' leading to a disciplined evaluation of smaller distributors.
Spine Fixation performance is bifurcated, with the top 30 distributors (80% of sales) performing well while smaller distributors face productivity challenges and potential consolidation or exits.
Biologics showed significant stabilization, moving from double-digit declines in 2025 to approximately flat year-over-year performance, driven by improved account engagement and utilization.
Therapeutic Solutions demonstrated resilience despite temporary reimbursement pressure, benefiting from steady demand and a strong margin profile.
#Potential #tell #management
Management is intentionally prioritizing commercial channel quality and long-term value creation over 'growth at all costs,' leading to a disciplined evaluation of smaller distributors.
Spine Fixation performance is bifurcated, with the top 30 distributors (80% of sales) performing well while smaller distributors face productivity challenges and potential consolidation or exits.
Biologics showed significant stabilization, moving from double-digit declines in 2025 to approximately flat year-over-year performance, driven by improved account engagement and utilization.
Therapeutic Solutions demonstrated resilience despite temporary reimbursement pressure, benefiting from steady demand and a strong margin profile.
#Potential #tell #management
18 days ago
